COCHE is proud to be one of the supporting units of the Hongqiao Cerebro-Cardiovascular (C2) Health Guardian Programme, organised by City University of Hong Kong (CityUHK) with the generous sponsorship of China Hongqiao Group Limited (Hongqiao). The Programme aims to enhance community health by providing free, comprehensive screening services for 5,000 residents of Light Public Housing and Transitional Housing in Kwun Tong, Sham Shui Po, Sha Tin and Tsuen Wan, with a focus on the early...

Cerebro-cardiovascular conditions have continued to pose a public health burden. The convergence of population ageing and lifestyle risk factors has made “earlier detection, earlier intervention, and accessible and affordable prevention and management” a common challenge for global healthcare systems. Concurrently, the rapid development of technologies such as Artificial Intelligence (AI), digital health platforms, and medical imaging has brought new possibilities for related risk assessment,...

The 2nd International Cerebro-cardiovascular Medical Innovation Summit (ICMIS 2025) will bring together global leaders to discuss cutting-edge research, innovative medical products, and cross-border collaborations to accelerate progress toward advanced cerebro-cardiovascular care worldwide.  Organized by the InnoHK Hong Kong Centre for Cerebro-cardiovascular Health Engineering (COCHE), the summit will serve as a unique and premium platform uniting leading clinicians, engineers,...